Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Association between pulmonary function and renal function: findings from China and Australia

Authors: Dahai Yu, Tao Chen, Yamei Cai, Zhanzheng Zhao, David Simmons

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

The relationship between obstructive lung function and impaired renal function is unclear. This study investigated the dose-response relationship between obstructive lung function and impaired renal function.

Methods

Two independent cross-sectional studies with representative sampling were applied. 1454 adults from rural Victoria, Australia (1298 with normal renal function, 156 with impaired renal function) and 5824 adults from Nanjing, China (4313 with normal renal function, 1511 with impaired renal function). Pulmonary function measurements included forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). Estimated glomerular filtration rate (eGFR), and impaired renal function marked by eGFR <60 mL/min/1.73m2 were used as outcome.

Results

eGFR increased linearly with FEV1 in Chinese participants and with FVC in Australians. A non-linear relationship with peaked eGFR was found for FEV1 at 2.65 L among Australians and for FVC at 2.78 L among Chinese participants, respectively. A non-linear relationship with peaked eGFR was found for the predicted percentage value of forced expiratory volume in 1 s (PFEV1) at 81–82% and for the predicted percentage value of forced vital capacity (PFVC) at 83–84% among both Chinese and Australian participants, respectively.
The non-linear dose-response relationships between lung capacity measurements (both for FEV1 and FVC) and risk of impaired renal function were consistently identified in both Chinese and Australian participants. An increased risk of impaired renal function was found below 3.05 L both for FEV1 and FVC, respectively. The non-linear relationship between PFEV and PVC and the risk of impaired renal function were consistently identified in both Chinese and Australian participants. An increased risk of impaired renal function was found below 76–77% for PFEV1 and 79–80% for PFVC, respectively.

Conclusions

In both Australian and Chinese populations, the risk of impaired renal function increased both with FEV1 and FVC below 3.05 L, with PFEV1 below 76–77% or with PFVC below 79–80%, respectively. Obstructive lung function was associated with increased risk of reduced renal function. The screen for impaired renal function in patients with obstructive lung disease might be useful to ensure there was no impaired renal function before the commencement of potentially nephrotoxic medication where indicated (eg diuretics).
Appendix
Available only for authorised users
Literature
1.
go back to reference Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A8, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A8, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed
2.
go back to reference Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM, Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383(9931):1831–43.CrossRefPubMed Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM, Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383(9931):1831–43.CrossRefPubMed
3.
go back to reference Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007–2012. Am J Kidney Dis. 2016;S0272–6386(16):30015–4. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007–2012. Am J Kidney Dis. 2016;S0272–6386(16):30015–4.
4.
go back to reference Yu D, Chen T, Qin R, Cai Y, Jiang Z, Zhao Z, Simmons D. Association between lung capacity and abnormal glucose metabolism: findings from China and Australia. Clin Endocrinol. 2016;85(1):37–45.CrossRef Yu D, Chen T, Qin R, Cai Y, Jiang Z, Zhao Z, Simmons D. Association between lung capacity and abnormal glucose metabolism: findings from China and Australia. Clin Endocrinol. 2016;85(1):37–45.CrossRef
5.
go back to reference Yu D, Simmons D. Association between lung capacity measurements and abnormal glucose metabolism: findings from the Crossroads study. Diabet Med. 2014;31(5):595–9.CrossRefPubMed Yu D, Simmons D. Association between lung capacity measurements and abnormal glucose metabolism: findings from the Crossroads study. Diabet Med. 2014;31(5):595–9.CrossRefPubMed
6.
go back to reference Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med. 2008;25(5):523–9.CrossRefPubMed Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med. 2008;25(5):523–9.CrossRefPubMed
7.
go back to reference Simmons D, Williams DR, Powell MJ. Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study. BMJ. 1989;298(6665):18–21.CrossRefPubMedPubMedCentral Simmons D, Williams DR, Powell MJ. Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study. BMJ. 1989;298(6665):18–21.CrossRefPubMedPubMedCentral
8.
go back to reference Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRefPubMed
9.
go back to reference Alberti KG, Zimmet P, Shaw J. IDF Epidemiology task force consensus group. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRefPubMed Alberti KG, Zimmet P, Shaw J. IDF Epidemiology task force consensus group. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRefPubMed
10.
go back to reference Simmons D, Shaw J, McKenzie A, Eaton S, Cameron AJ, Zimmet P. Is grand multiparity associated with an increased risk of dysglycaemia? Diabetologia. 2006;49(7):1522–7.CrossRefPubMed Simmons D, Shaw J, McKenzie A, Eaton S, Cameron AJ, Zimmet P. Is grand multiparity associated with an increased risk of dysglycaemia? Diabetologia. 2006;49(7):1522–7.CrossRefPubMed
11.
go back to reference Simmons D, McKenzie A, Eaton S, Shaw J, Zimmet P. Prevalence of diabetes in rural Victoria. Diabetes Res Clin Pract. 2005;70(3):287–90.CrossRefPubMed Simmons D, McKenzie A, Eaton S, Shaw J, Zimmet P. Prevalence of diabetes in rural Victoria. Diabetes Res Clin Pract. 2005;70(3):287–90.CrossRefPubMed
12.
go back to reference Yu D, Simmons D. Association between blood pressure and risk of cardiovascular hospital admissions among people with type 2 diabetes. Heart. 2014;100(18):1444–9.CrossRefPubMed Yu D, Simmons D. Association between blood pressure and risk of cardiovascular hospital admissions among people with type 2 diabetes. Heart. 2014;100(18):1444–9.CrossRefPubMed
13.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI (chronic kidney disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. CKD-EPI (chronic kidney disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral
14.
go back to reference Skali H, Uno H, Levey AS, Inker LA, Pfeffer MA, Solomon SD. Prognostic assessment of estimated glomerular filtration rate by the new chronic kidney disease Epidemiology Collaboration equation in comparison with the modification of diet in renal disease study equation. Am Heart J. 2011;162(3):548–54.CrossRefPubMed Skali H, Uno H, Levey AS, Inker LA, Pfeffer MA, Solomon SD. Prognostic assessment of estimated glomerular filtration rate by the new chronic kidney disease Epidemiology Collaboration equation in comparison with the modification of diet in renal disease study equation. Am Heart J. 2011;162(3):548–54.CrossRefPubMed
15.
go back to reference Yu D, Simmons D. Association between pulse pressure and risk of hospital admissions for cardiovascular events among people with type 2 diabetes: a population-based case-control study. Diabet Med. 2015;32(9):1201–6.CrossRefPubMed Yu D, Simmons D. Association between pulse pressure and risk of hospital admissions for cardiovascular events among people with type 2 diabetes: a population-based case-control study. Diabet Med. 2015;32(9):1201–6.CrossRefPubMed
16.
go back to reference Yu D, Simmons D. Relationship between HbA1c and risk of all-cause hospital admissions among people with type 2 diabetes. Diabet Med. 2013;30(12):1407–11.CrossRefPubMed Yu D, Simmons D. Relationship between HbA1c and risk of all-cause hospital admissions among people with type 2 diabetes. Diabet Med. 2013;30(12):1407–11.CrossRefPubMed
17.
go back to reference Lange P, Parner J, Schnohr P, Jensen G. Copenhagen city heart study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J. 2002;20(6):1406–12.CrossRefPubMed Lange P, Parner J, Schnohr P, Jensen G. Copenhagen city heart study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J. 2002;20(6):1406–12.CrossRefPubMed
18.
go back to reference Atkinson RW, Yu D, Armstrong BG, Pattenden S, Wilkinson P, Doherty RM, Heal MR, Anderson HR. Concentration-response function for ozone and daily mortality: results from five urban and five rural U.K. populations. Environ Health Perspect. 2012;120(10):1411–7. Atkinson RW, Yu D, Armstrong BG, Pattenden S, Wilkinson P, Doherty RM, Heal MR, Anderson HR. Concentration-response function for ozone and daily mortality: results from five urban and five rural U.K. populations. Environ Health Perspect. 2012;120(10):1411–7.
19.
go back to reference Eriksson KF, Lindgarde F. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia. 1996;39(5):573–9.CrossRefPubMed Eriksson KF, Lindgarde F. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia. 1996;39(5):573–9.CrossRefPubMed
20.
go back to reference Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.CrossRefPubMed Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.CrossRefPubMed
21.
go back to reference Nakade Y, Toyama T, Furuichi K, Kitajima S, Ohkura N, Sagara A, Shinozaki Y, Hara A, Kitagawa K, Shimizu M, Iwata Y, Oe H, Nagahara M, Horita H, Sakai Y, Kaneko S, Wada T. Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2014;18(5):763–9.CrossRefPubMed Nakade Y, Toyama T, Furuichi K, Kitajima S, Ohkura N, Sagara A, Shinozaki Y, Hara A, Kitagawa K, Shimizu M, Iwata Y, Oe H, Nagahara M, Horita H, Sakai Y, Kaneko S, Wada T. Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2014;18(5):763–9.CrossRefPubMed
22.
go back to reference van Gestel YR, Chonchol M, Hoeks SE, Welten GM, Stam H, Mertens FW, van Domburg RT, Poldermans D. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant. 2009;24(9):2763–7.CrossRefPubMed van Gestel YR, Chonchol M, Hoeks SE, Welten GM, Stam H, Mertens FW, van Domburg RT, Poldermans D. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant. 2009;24(9):2763–7.CrossRefPubMed
23.
go back to reference Udani SM, Dieter RS. Inflammation in renal atherosclerotic disease. Expert Rev Cardiovasc Ther. 2008;6(6):873–81.CrossRefPubMed Udani SM, Dieter RS. Inflammation in renal atherosclerotic disease. Expert Rev Cardiovasc Ther. 2008;6(6):873–81.CrossRefPubMed
24.
go back to reference Lin CY, Lin LY, Kuo HK, Lin JW. Chronic kidney disease, atherosclerosis, and cognitive and physical function in the geriatric group of the National Health and Nutrition survey 1999-2002. Atherosclerosis. 2009;202(1):312–9.CrossRefPubMed Lin CY, Lin LY, Kuo HK, Lin JW. Chronic kidney disease, atherosclerosis, and cognitive and physical function in the geriatric group of the National Health and Nutrition survey 1999-2002. Atherosclerosis. 2009;202(1):312–9.CrossRefPubMed
25.
go back to reference Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–9.CrossRefPubMed Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–9.CrossRefPubMed
27.
go back to reference Baines KJ, Backer V, Gibson PG, Powel H, Porsbjerg CM. Impaired lung function is associated with systemic inflammation and macrophage activation. Eur Respir J. 2015;45(2):557–9.CrossRefPubMed Baines KJ, Backer V, Gibson PG, Powel H, Porsbjerg CM. Impaired lung function is associated with systemic inflammation and macrophage activation. Eur Respir J. 2015;45(2):557–9.CrossRefPubMed
Metadata
Title
Association between pulmonary function and renal function: findings from China and Australia
Authors
Dahai Yu
Tao Chen
Yamei Cai
Zhanzheng Zhao
David Simmons
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0565-y

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue